Literature DB >> 15129716

Re: controversies--[Tc(CO)3]+ chemistry: a promising new concept for SPET?

James R Ballinger, Margaret S Cooper, Stephen J Mather.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15129716     DOI： 10.1007/s00259-003-1374-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  9 in total

Review 1.  The influence of carrier on 99mTc radiopharmaceuticals.

Authors:  J R Ballinger
Journal:  Q J Nucl Med       Date:  2002-09

Review 2.  Current use and future potential of organometallic radiopharmaceuticals.

Authors:  Roger Schibli; P August Schubiger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-08-06       Impact factor: 9.236

3.  Is PET the future of nuclear medicine?

Authors:  Michael Maisey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-06-21       Impact factor: 9.236

4.  [Tc(CO)(3)](+) chemistry: a promising new concept for SPET? For.

Authors:  Roger Alberto
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-07-29       Impact factor: 9.236

5.  [Tc(CO)(3)](+) chemistry: a promising new concept for SPECT? Against.

Authors:  Michael J Welch; Jason S Lewis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-07-26       Impact factor: 9.236

6.  99mTc-HYNIC-folate: a novel receptor-based targeted radiopharmaceutical for tumor imaging.

Authors:  W Guo; G H Hinkle; R J Lee
Journal:  J Nucl Med       Date:  1999-09       Impact factor: 10.057

7.  Organometallic 99mTc-aquaion labels peptide to an unprecedented high specific activity.

Authors:  A Egli; R Alberto; L Tannahill; R Schibli; U Abram; A Schaffland; R Waibel; D Tourwé; L Jeannin; K Iterbeke; P A Schubiger
Journal:  J Nucl Med       Date:  1999-11       Impact factor: 10.057

8.  99mTc-Labeling of a hydrazinonicotinamide-conjugated LTB(4) receptor antagonist useful for imaging infection and inflammation.

Authors:  Shuang Liu; Anthony R Harris; Neal E Williams; D Scott Edwards
Journal:  Bioconjug Chem       Date:  2002 Jul-Aug       Impact factor: 4.774

9.  Radiolabeled neurotensin analog, 99mTc-NT-XI, evaluated in ductal pancreatic adenocarcinoma patients.

Authors:  Franz Buchegger; Florent Bonvin; Marek Kosinski; Andreas O Schaffland; John Prior; Jean C Reubi; Peter Bläuenstein; Dirk Tourwé; Elisa García Garayoa; Angelika Bischof Delaloye
Journal:  J Nucl Med       Date:  2003-10       Impact factor: 10.057
  9 in total
  4 in total

1.  Synthesis and preliminary evaluation of radiolabeled bis(zinc(II)-dipicolylamine) coordination complexes as cell death imaging agents.

Authors:  Leonie Wyffels; Brian D Gray; Christy Barber; Stephen K Moore; James M Woolfenden; Koon Y Pak; Zhonglin Liu
Journal:  Bioorg Med Chem       Date:  2011-04-28       Impact factor: 3.641

2.  Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels.

Authors:  Vladimir Tolmachev; Helena Wållberg; Mattias Sandström; Monika Hansson; Anders Wennborg; Anna Orlova
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-11       Impact factor: 9.236

3.  SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression.

Authors:  Lieven Huang; Lea Olive Tchouate Gainkam; Vicky Caveliers; Chris Vanhove; Marleen Keyaerts; Patrick De Baetselier; Axel Bossuyt; Hilde Revets; Tony Lahoutte
Journal:  Mol Imaging Biol       Date:  2008-02-23       Impact factor: 3.488

4.  Preparation and properties of 99mTc(CO)3+-labeled N,N-bis(2-pyridylmethyl)-4-aminobutyric acid.

Authors:  Guozheng Liu; Shuping Dou; Jiang He; Jean-Luc Vanderheyden; Mary Rusckowski; Donald J Hnatowich
Journal:  Bioconjug Chem       Date:  2004 Nov-Dec       Impact factor: 4.774
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.